Please provide your email address to receive an email when new articles are posted on . Developed jointly with Ionis Pharmaceuticals, bepirovirsen is intended to curb viral DNA replication, reduce the ...
(RTTNews) - Ionis Pharmaceuticals Inc. (IONS) announced that GSK presented positive results from an interim analysis of the Phase 2b B-Clear clinical study of bepirovirsen (formerly IONIS-HBVRx), an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results